CEL Sci Corp: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on May 12, 2014 and accepted by EDGAR at May 12, 2014, 20:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2014-01-01 to 2014-03-31 | $4.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2013-10-01 to 2014-03-31 | $8.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2014-01-01 to 2014-03-31 | −$6.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-10-01 to 2014-03-31 | −$12.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-01-01 to 2014-03-31 | $37.7k | us-gaap:InterestExpense |
| Interest expense | 6 months2013-10-01 to 2014-03-31 | $80.4k | us-gaap:InterestExpense |
| Net income | 3 months2014-01-01 to 2014-03-31 | −$13.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2013-10-01 to 2014-03-31 | −$17.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | −$0.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2013-10-01 to 2014-03-31 | −$0.36 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-01-01 to 2014-03-31 | −$0.24 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2013-10-01 to 2014-03-31 | −$0.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-01-01 to 2014-03-31 | 56,239,562 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2013-10-01 to 2014-03-31 | 52,183,654 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2013-10-01 to 2014-03-31 | −$11.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2013-10-01 to 2014-03-31 | $27.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-03-31 | $10.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-03-31 | $13.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-03-31 | $21.8m | us-gaap:Assets |
| Current liabilities | At period end2014-03-31 | $3.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-03-31 | $14.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-03-31 | $7.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001354488-14-002441. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.